- Report
- September 2025
- 529 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 216 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- December 2024
- 200 Pages
Global
From €3296EUR$3,750USD£2,851GBP
- Report
- August 2025
- 136 Pages
Global
From €2636EUR$2,999USD£2,280GBP
- Report
- May 2025
- 139 Pages
Global
From €2636EUR$2,999USD£2,280GBP
- Report
- April 2025
- 146 Pages
Global
From €2636EUR$2,999USD£2,280GBP
- Report
- January 2025
- 125 Pages
Global
From €2636EUR$2,999USD£2,280GBP
- Report
- August 2025
- 199 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- June 2025
- 180 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- June 2025
- 185 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- May 2025
- 185 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- May 2025
- 190 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- January 2025
- 182 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- June 2025
- 183 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- July 2025
- 363 Pages
Global
From €3911EUR$4,450USD£3,383GBP
- Report
- February 2025
- 148 Pages
Global
From €2778EUR$3,160USD£2,403GBP
€3472EUR$3,950USD£3,003GBP
- Report
- December 2024
- 120 Pages
Global
From €2778EUR$3,160USD£2,403GBP
€3472EUR$3,950USD£3,003GBP
- Report
- November 2024
- 159 Pages
Global
From €2197EUR$2,500USD£1,901GBP
- Report
- August 2025
- 150 Pages
Global
From €2951EUR$3,358USD£2,553GBP
€3472EUR$3,950USD£3,003GBP
- Report
- August 2025
- 150 Pages
Global
From €2951EUR$3,358USD£2,553GBP
€3472EUR$3,950USD£3,003GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more